PNPLA2 and cancer: demonstrated that, in hypoxia, hypoxia-inducible gene 2 (HIG2), as a novel endogenous inhibitor of ATGL, mediates the lipolytic inhibition, promotes LD accumulation, attenuates ROS production, and enhances cancer cell survival (48).